Veterinary Infectious Disease Diagnostics Market Growth & Trends 2035

Market Overview

The global veterinary infectious disease diagnostics market share was valued at nearly USD 2.11 billion in 2025 and is poised for strong expansion over the next decade. Driven by rising animal health concerns, increasing pet ownership, and heightened awareness of zoonotic diseases, the market is expected to grow at a CAGR of around 9.00 percent during the forecast period of 2026-2035, reaching approximately USD 5.00 billion by 2035. Veterinary infectious disease diagnostics play a crucial role in early detection, disease control, and prevention, supporting both animal welfare and public health outcomes.

Key Growth Drivers

Rising Incidence of Infectious and Zoonotic Diseases

One of the primary drivers of the veterinary infectious disease diagnostics market is the increasing prevalence of infectious diseases among both companion and food-producing animals. Diseases such as avian influenza, foot-and-mouth disease, brucellosis, and parasitic infections pose significant economic and health risks. Growing awareness of zoonotic disease transmission from animals to humans is prompting governments, veterinarians, and livestock producers to invest in advanced diagnostic solutions.

Request a Free Sample Report With Table of Contents

Growth in Companion Animal Ownership

The global rise in pet ownership, particularly dogs and cats, is significantly boosting demand for veterinary diagnostic testing. Pet owners are increasingly willing to spend on preventive healthcare, routine screening, and early diagnosis of infectious diseases. This trend is especially prominent in urban regions, where companion animals are treated as family members, supporting sustained demand for accurate and rapid diagnostic technologies.

Advancements in Diagnostic Technologies

Technological innovation is transforming the veterinary diagnostics landscape. Molecular diagnostics and advanced immunodiagnostics are enabling faster, more accurate detection of pathogens. Techniques such as PCR-based testing and ELISA assays are gaining traction due to their high sensitivity and specificity. Continuous improvements in point-of-care diagnostics are further enhancing accessibility and adoption in veterinary clinics and field settings.

Expansion of Livestock and Animal Protein Demand

The growing global demand for animal-derived food products is driving the expansion of commercial livestock farming. This increases the need for effective disease surveillance and diagnostic testing to maintain herd health, improve productivity, and comply with food safety regulations. Veterinary diagnostics are becoming essential tools for disease management in large-scale food-producing animal operations.

Market Challenges

High Cost of Advanced Diagnostic Solutions

Despite strong growth prospects, the market faces challenges related to the high cost of advanced diagnostic equipment and testing procedures. Small veterinary clinics and farmers in developing regions may find it difficult to afford molecular diagnostic systems, limiting adoption. Cost sensitivity remains a key barrier, particularly in price-driven markets.

Limited Veterinary Infrastructure in Emerging Regions

In several low- and middle-income countries, limited access to veterinary healthcare infrastructure and diagnostic laboratories restricts market penetration. Shortages of trained veterinary professionals and lack of awareness about early disease detection further hinder growth in these regions.

Regulatory and Validation Complexities

Veterinary diagnostic products must meet stringent regulatory and validation requirements before commercialization. Differences in regulatory frameworks across regions can delay product approvals and increase compliance costs for manufacturers, posing a challenge to market expansion.

Market Segmentation Insights

By Technology

The market is segmented into immunodiagnostics, molecular diagnostics, and other technologies. Immunodiagnostics account for a significant share due to their widespread use, cost-effectiveness, and ease of application. Molecular diagnostics are expected to witness the fastest growth, driven by demand for high-precision and rapid pathogen detection.

By Animal Type

Companion animals represent a major market segment due to rising pet ownership and increasing veterinary visits. Food-producing animals also account for a substantial share, supported by the need for disease surveillance, biosecurity, and compliance with food safety standards.

By End Use

Key end users include veterinary hospitals and clinics, diagnostic laboratories, and research institutions. Veterinary clinics dominate the market due to routine testing and preventive care practices, while diagnostic laboratories are gaining importance for specialized and high-throughput testing.

Regional Analysis

North America holds a leading position in the veterinary infectious disease diagnostics market, supported by advanced veterinary infrastructure, high pet healthcare spending, and strong regulatory frameworks. Europe follows closely, driven by animal welfare regulations and growing awareness of zoonotic diseases. The Asia-Pacific region is expected to experience the fastest growth, fueled by expanding livestock production, increasing pet adoption, and improving veterinary healthcare access.

Market Dynamics

SWOT Analysis

Strengths include technological innovation and growing awareness of animal health. Weaknesses involve high costs and uneven infrastructure. Opportunities lie in emerging markets and point-of-care diagnostics, while threats include regulatory complexity and price competition.

Porter’s Five Forces Analysis

The threat of new entrants is moderate due to regulatory barriers and technology requirements. Buyer power is moderate, supplier power is relatively low, threat of substitutes is limited, and competitive rivalry remains high due to continuous innovation.

Competitive Landscape

The veterinary infectious disease diagnostics market is moderately competitive, with key players focusing on product innovation, geographic expansion, and strategic collaborations. Major companies operating in the market include Biomerieux S.A., Chembio Diagnostics, Inc., IDEXX Laboratories, Inc., INDICAL BIOSCIENCE GmbH, and Jayalakshmi Sea Foods Pvt. Ltd. These players are investing in advanced diagnostic platforms and expanding their test portfolios to strengthen market presence during the 2026-2035 period.